Abstract:AimsStress granules (SGs) are transient cytoplasmic mRNA and protein complexes that form in eukaryotic cells under stress. SGs are related to multiple diseases, but there are no reports of the existence of SGs in atrial fibrillation (AF).Methods and resultsCell models of AF were established by field stimulation at 600 times per minute. HL-1 cells, cardiomyocytes and cardiac fibroblasts were transfected with G3BP1-cDNA plasmid by Lipofectamine 2000. The presence of SGs was detected by immunofluorescence analysis against GTPase-activating protein SH3 domain binding protein 1 (G3BP1) and poly(A)-binding protein 1 (PABP-1) and electron microscopy. Stable HL-1 cell lines transfected with lenti-virus overexpressing G3BP1 were constructed to further induce the formation of SGs in AF. Reactive oxygen species (ROS) and calcium overload in tachypaced HL-1 cells were studied by flow cytometry. The effects of G3BP1 overexpression on cardiac fibroblast proliferation and the protein expression level of collagen I/III and fibronectin-1 were also studied. Additionally, we detected protein synthesis in general and in single cells by puromycin incorporation in paced HL-1 cells. Here, we first showed that SGs are present in both tachypaced mouse cardiomyocytes and HL-1 atrial cells, although the presence is partial and at a low level. G3BP1 overexpression promoted SG formation, inhibited the rapid pacing-induced increase in ROS level, and attenuated calcium overload in HL-1 cells (all P<0.05). Furthermore, G3BP1 overexpression inhibited cardiac fibroblast proliferation (P<0.05) and decreased the protein expression level of collagen I and fibronectin-1 in cardiac fibroblasts stimulated by angiotensin II (all P<0.05). The bulk puromycin incorporation analyzed by Western blot did not show a global reduction in protein synthesis. However, puromycin incorporation in single cells detected by immunofluorescence analysis showed that protein synthesis in SG-containing cells significantly reduced (P<0.01).ConclusionsSGs are rapidly induced and present parially in AF, and G3BP1 overexpression promotes SG formation and confers cytoprotection against oxidative stress, calcium overload and atrial fibrosis in AF.

Stress Granules in Atherosclerosis: Insights and Therapeutic Opportunities

Friend or Foe: the Role of Stress Granule in Neurodegenerative Disease

Targeting stress granules: A novel therapeutic strategy for human diseases

Stress granules in cancer: Adaptive dynamics and therapeutic implications

Aberrant Stress Granule Dynamics and Aggrephagy in ALS Pathogenesis

The involvement of stress granules in aging and aging‐associated diseases

Chronic Stress A Potential Suspect Zero of Atherosclerosis: A Systematic Review

Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment

Stress granules: potential therapeutic targets for infectious and inflammatory diseases

The Role of Inflammatory Stress in Acute Coronary Syndrome

A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules

Stress Granule: A Promising Target For Cancer Treatment

Presence And Function Of Stress Granules In Atrial Fibrillation

Shear Stress and Metabolic Disorders—Two Sides of the Same Plaque

Xiaoyaosan Prevents Atherosclerotic Vulnerable Plaque Formation Through Heat Shock Protein/glucocorticoid Receptor Axis-Mediated Mechanism.

Response to stress in biological disorders: Implications of stress granule assembly and function

Molecular chaperones and heat shock proteins in atherosclerosis

Oxidative Stress in Atherosclerosis

Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies

High shear stress induces atherosclerotic vulnerable plaque formation through angiogenesis

Chronic stress: a critical risk factor for atherosclerosis